ViaDerma, Inc. engages with the manufacturing and sales of pharmaceutical related products. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2008-06-10. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The firm also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. The products are based on a patent pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The firm utilizes a specific trade secret formulation system in the manufacture of all products. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Follow-Up Questions
What is Viaderma Inc (VDRM)'s P/E Ratio?
The P/E ratio of Viaderma Inc is 0.0924
Who is the CEO of Viaderma Inc?
Rui Sheng Liu is the President of Viaderma Inc, joining the firm since 2009.
What is the price performance of VDRM stock?
The current price of VDRM is $0.0001, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Viaderma Inc?
Viaderma Inc belongs to Pharmaceuticals industry and the sector is Health Care
